medigraphic.com
SPANISH

Revista Cubana de Farmacia

ISSN 1561-2988 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 1

<< Back Next >>

Rev Cubana Farm 2011; 45 (1)

Chemical compatibility of 3 mg Auranofin tablets demonstrated by differential scanning calorimetry and thermogravimetry

Martínez ÁLO; Montes PM
Full text How to cite this article

Language: Spanish
References: 9
Page: 43-49
PDF size: 59.27 Kb.


Key words:

differential scanning calorimetry, thermogravimetry, Auranofin.

ABSTRACT

As part of the pre-stability study of the Auranofin tablet pre-formulation, a chemical compatibility study was conducted using thermal analysis techniques such as the differential scanning calorimetry and the thermogravimetry. Prior to these studies, the active principle and each of the excipients were thermally characterized with the aid of the differential scanning calorimetry. Then, there proceeded to carry out the chemical compatibility study by preparing binary physical mixtures between the active principle and each of the excipients. Both methods showed that the active principle had a melting physical transition, not reported in the literature, which allowed calculating its purity aided by the differential scanning calorimetry. It was possible to infer from the calorimetry technique that there was not chemical incompatibility between the active principle and the studied excipients. By means of the activation energy estimation, the following order of thermal stability was set: Auranofin:PVP> Auranofin: lactose> Auranofin:explotab> Auranofin:estearate> Auranofin:aerosil> Auranofin:celullose. The use of these excipients was recommended for the preparation of the pharmaceutical formulation.


REFERENCES

  1. Ministerio de Salud. Guía Clínica Artritis Reumatoide. Santiago: MINSAL; 2007.

  2. Anonymous. Drug for rheumatoid arthritis. Med Lett. Drugs Ther. 1991;3:65-70.

  3. Furst DE. Rational use of disease-modifying antirheumatic drugs. Drugs. 1990;39:19-37.

  4. Hart.LE, Tugwell P. The use of disease-modifying antirheumatic drugs in the management of rheumatoid arthritis. Postgrad Med J. 1989;65:905-12.

  5. 5 Ford JL, Timmis P. Pharmaceutical Thermal Analysis, Techniques and applications. New York: John Wiley Sons; 1988.

  6. 6 Venkataram S, Khohlokwane M, Wallis SH. Differential scanning calorimetry as a quick scanning technique for solid state stability studies. Drug Dev Industrial Pharm. 1995; 21(7):847-55.

  7. 7 Budavari S. The Merck Index. 11 ed. New York: Merck; 1989. p. 898.

  8. 8 Gennaro AR. Remington: The Science and Practice of Pharmacy, 19th ed. Easton: Mack Publishing; 1995.

  9. 9 American Pharmaceutical Association and Pharmaceutical Press. Handbook of Pharmaceutical Excipients. CD-ROM. Washington: Pharmaceutical Press; 2000.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Farm. 2011;45